Live Breaking News & Updates on கரோலினா பயோடெக் மையம்

Stay updated with breaking news from கரோலினா பயோடெக் மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Four New Biotechs to Watch: Esker, Mogrify, Isolere and BridGene


Published: May 05, 2021
By Mark Terry
There’s money on the move and venture capital firms launch several biotech companies with hefty Series A financing rounds. Here’s a look.
Esker Launches with $70 Million Series A
San Francisco-based Esker Therapeutics, a Foresite Labs-incubated company,
launched with a $70 million Series A financing. The round was led by Foresite Capital. The company focuses on autoimmune diseases and so-called precision therapies that target patients most likely to benefit from them.
The company’s precision analytics platform is powered by Foresite Labs. The technology platform is made up of high-quality curated genetic, clinical and medical record data, a systems immunology approach for prospective data collections and tools for building patient registries. Its lead pipeline product is ESK-001, a highly selective TYK2 inhibitor with greater selectivity for TYK2 over JAK1, initially in development for psoriasis. It is ....

United Kingdom , North Carolina , United States , Duke University , Jonathan Milner , Kelli Luginbuhl , June Lee , Ashutosh Chilkoti , Joe Mcmahon , Isolere Bio , Darrinm Disley , Carolina Biotech Center , National Institutes Of Health , National Science Foundation , Esker Therapeutics , Foresite Labs Incubated , Mogrify Limited , Parkwalk Advisors , Astellas Venture Management , Jonathan Miler , Bio Raises , National Institutes , North Carolina Biotech , Gene Closes , California Based Bridgene , Wedo Venture Partners ,

Female-led Duke biotech spinout Isolere Bio closes $7M in seed funding


by Chantal Allam May 5, 2021 .
DURHAM – Isolere Bio, a Duke University, female-led spinout focused on “reimagining the manufacturing of complex therapeutics,” has landed $7 million in seed funding from lead investor Northpond Ventures.
It’s now getting ready to scale.
“We are thrilled to be teaming up with a top-tier, science-driven investor who believes in and shares our mission of delivering technologies for a healthier and safer world,” said Kelli Luginbuhl, Ph.D., Isolere’s founder and CEO.
The funding will support “development, scaleup, and commercialization” of its most advanced purification technology platform.
Kelli Luginbuhl, Ph.D., Isolere’s founder and CEO ....

North Carolina , United States , Duke University , Isolere Isotag , Kelli Luginbuhl , Adam Wieschhaus , Ashutosh Chilkoti , Joe Mcmahon , Isolere Bio , Carolina Biotech Center , National Institutes Of Health , Chilkoti Laboratory At Duke University , National Science Foundation , Chilkoti Laboratory , National Institutes , North Carolina Biotech , வடக்கு கரோலினா , ஒன்றுபட்டது மாநிலங்களில் , டியூக் பல்கலைக்கழகம் , கெல்லி லுகிண்புல் , ஓஹோ மக்மேயந் , கரோலினா பயோடெக் மையம் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , தேசிய அறிவியல் அடித்தளம் , தேசிய நிறுவனங்கள் , வடக்கு கரோலினா பயோடெக் ,